{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:49:46Z","timestamp":1791589786484,"version":"4.3.4"},"reference-count":24,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014421","name":"EA Pharma Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aim<\/jats:title>\n                    <jats:p>Elobixibat is a locally acting inhibitor of the ileal bile acid transporter. We compared bile acid metabolism between healthy subjects and patients with chronic constipation and assessed changes in the bile acid profile after elobixibat administration in the latter group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Healthy subjects (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a010) and patients with chronic constipation (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a019) were assessed as inpatients for 7\u00a0days, during which they received meals containing ~60\u00a0g\/day of fat. Patients with chronic constipation remained as inpatients for a further 7\u00a0days for once\u2010daily elobixibat administration. Assessments included concentrations of fecal and serum bile acids, serum 7\u03b1\u2010hydroxy\u20104\u2010cholesten\u20103\u2010one (C4) and fibroblast growth factor 19, and bowel movements and constipation symptoms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fecal total and primary bile acids were significantly lower in patients with chronic constipation\n                      <jats:italic>versus<\/jats:italic>\n                      healthy subjects. Serum C4 and fibroblast growth factor 19 levels were comparable between groups. Elobixibat treatment increased fecal total and primary bile acids and decreased levels of fecal lithocholic acid and serum total as well as secondary bile acids in patients with chronic constipation. Bowel movements and other constipation\u2010related symptoms were also improved by elobixibat to levels almost comparable with those of healthy subjects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Despite comparable C4 levels, patients with chronic constipation demonstrated decreased levels of fecal bile acids\n                      <jats:italic>versus<\/jats:italic>\n                      healthy subjects. Elobixibat treatment increased fecal bile acid excretion and reduced serum bile acid concentrations. The improvement of constipation after elobixibat treatment was associated with increased total bile acids, particularly primary bile acids.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jgh.15800","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T19:03:12Z","timestamp":1644951792000},"page":"883-890","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation"],"prefix":"10.1111","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6263-1436","authenticated-orcid":false,"given":"Atsushi","family":"Nakajima","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology Yokohama City University  Yokohama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonoko","family":"Ishizaki","sequence":"additional","affiliation":[{"name":"EA Pharma Co., Ltd.  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Matsuda","sequence":"additional","affiliation":[{"name":"EA Pharma Co., Ltd.  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Kurosu","sequence":"additional","affiliation":[{"name":"EA Pharma Co., Ltd.  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"EA Pharma Co., Ltd.  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per\u2010G\u00f6ran","family":"Gillberg","sequence":"additional","affiliation":[{"name":"Albireo AB  Gothenburg Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P","family":"Mattsson","sequence":"additional","affiliation":[{"name":"Albireo AB  Gothenburg Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Hasunuma","sequence":"additional","affiliation":[{"name":"Kitasato University Kitasato Institute Hospital  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-7514","authenticated-orcid":false,"given":"Michael","family":"Camilleri","sequence":"additional","affiliation":[{"name":"Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106644"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00194.2001"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(10)61017-7"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.5493"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R500013-JLR200"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31816920a6"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.048074"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.06.039"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2015.1127483"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.119"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30123-7"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109020"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840200612"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(87)90045-3"},{"key":"e_1_2_6_16_1","unstructured":"Ministry of Health Labour and Welfare.The National Health and Nutrition Survey in Japan 2016. Available at:https:\/\/www.mhlw.go.jp\/bunya\/kenkou\/eiyou\/dl\/h28\u2010houkoku.pdf(accessed July 2021)."},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-019-1102-1"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15106"},{"key":"e_1_2_6_19_1","first-page":"661","article-title":"Effect of molecular structure on bile acid\u2010induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon","volume":"94","author":"Chadwick VS","year":"1979","journal-title":"J. Lab. Clin. Med."},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13457"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15950"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13698"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12829"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04675.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.285"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgh.15800","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jgh.15800","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgh.15800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T04:39:17Z","timestamp":1692679157000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jgh.15800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1111\/jgh.15800"],"URL":"https:\/\/doi.org\/10.1111\/jgh.15800","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"assertion":[{"value":"2021-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}